| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 1.30 | 11.0% | 15.6% |
| Total Income | 1.30 | 11.0% | 15.6% |
| Expenditure | 2.45 | 25.0% | 25.8% |
| PBT | — | ||
| Net Profit | 0.86 | 119.3% | 153.4% |
| OPM | -88.48% | 54.05pp | |
| NPM | 65.75% | ||
| EPS | 0.63 | 119.3% | 153.4% |
Arcadia Biosciences Reports Q3 2025 Results; Zola YTD Revenue Up 26%
04 May 2026 · 4 May, 7:38 am
Summary
Arcadia Biosciences announced its third-quarter 2025 financial results, with Zola® coconut water revenues showing a 26% year-to-date increase. The company's gross profit margins exceeded 30% for the eleventh consecutive quarter. Total revenues for the third quarter decreased by 15% to $1.302 million compared to the same period in 2024, primarily due to the absence of GLA oil sales in 2025. Net income attributable to common stockholders improved to $856,000 for the third quarter of 2025, compared to a $1.6 million net loss in the third quarter of 2024.
Key Highlights
- 1
Arcadia Biosciences' Zola® year-to-date revenues increased 26% year over year.
- 2
The company's gross profit margins exceeded 30% for the eleventh straight quarter.
- 3
Arcadia's cash balance declined by only $257K to $1.1M.
- 4
Total revenues decreased by 15% to $1.302 million during the third quarter of 2025 compared to $1.537 million in the same period in 2024.
- 5
Net income attributable to common stockholders for the third quarter of 2025 was $856,000, a $2.5 million improvement from the $1.6 million net loss for the third quarter of 2024.
- 6
Zola revenues increased $820,000, or 26% during the first nine months of 2025 compared to the same period in 2024.
- 7
SG&A decreased by $671,000 during the third quarter of 2025 compared to the same period in 2024.
Management Comments
T.J. Schaefer
“We are very pleased with our performance for the third quarter of 2025.” “Zola® coconut water revenues were flat year-over-year in the third quarter as we overlapped the initial sell-in to Zola’s largest customer during the third quarter of 2024. However, on a year-to-date basis, Zola coconut water revenues have grown 26% and more than offset $700,000 in GLA sales in 2024 that did not occur in 2025. Additionally, our gross margins have now exceeded 30% for eleven consecutive quarters, SG&A expenses are at an all-time low and our cash management exceeded our expectations. “In addition to our strong operating performance, we continue to own 2.7 million shares of Above Food Ingredients Inc. stock as a partial repayment of the $6 million principal amount of the note receivable related to the sale of GoodWheatTM assets in the second quarter of 2024 and are pursuing resolution of the remaining outstanding balance. “Our pending business combination with Roosevelt Resources is still in progress,” Schaefer continued, “but uncertainty exists regarding the timing due to several factors including the ongoing federal government shutdown that went into effect over a month ago. We continue to monitor events closely, but the shutdown is obviously a situation that is outside of our control.”
Informational and educational content only. Not investment advice.